Windtree (WINT) Stock Climbs In Pre-Market Trading After Major Update
The disclosure of progress in a clinical study has resulted in a large boost in the stock value of Windtree Therapeutics, Inc. (NASDAQ: WINT). As of the latest pre-hours check, Windtree stock has risen 55.12% to $4.95. Windtree Completed Enrollment In A Significant Study The SEISMiC Extension Phase 2b trial, conducted by Windtree Therapeutics to […]
Windtree (WINT) Stock Climbs In Pre-Market Trading After Major Update Read More »